FindTrial
Sign In

Determination of the ED95 of a single bolus dose of remimazolam tosilate for adequate sedation in children: A biased coin design up-and-down sequential method.

Determination of the ED95 of a single bolus dose of remimazolam tosilate for adequate sedation in children: A biased coin design up-and-down sequential method.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075986
Enrollment
Unknown
Registered
2023-09-21
Start date
2023-10-01
Completion date
Unknown
Last updated
2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

infant group:remimazolam tosilate
Preschool group:remimazolam tosilate
school-age groups:remimazolam tosilate

Sponsors

Southern District of the First Affiliated Hospital of University of science and technology of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 12 Years

Inclusion criteria

Inclusion criteria: ?Children who undergo elective surgical procedure; ? General anesthesia; ? Aged 1-12 years ? ASA physical status I-II;

Exclusion criteria

Exclusion criteria: ? Allergy to remimazolam tosilate; ? History of respiratory, hepatic, renal, liver disease ? History of nervous system disease or mental retardation; ? History of sedative or anticonvulsant drugs before surgery

Design outcomes

Primary

MeasureTime frame
the ED95 of a single bolus dose of remimazolam tosilate for adequate sedation in children;—

Secondary

MeasureTime frame
Mean arterial pressure;SPO2;heart rate;Wake-up time;—

Countries

China

Contacts

Public ContactYang Chengwei

Southern District of the First Affiliated Hospital of University of science and technology of China

yangcw1108@ustc.edu.cn+86 130 1303 1356

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026